Swiss National Bank Purchases 23,440 Shares of Humana Inc. $HUM

Swiss National Bank increased its position in shares of Humana Inc. (NYSE:HUM) by 7.1% in the first quarter, Holdings Channel.com reports. The firm owned 352,960 shares of the insurance provider’s stock after purchasing an additional 23,440 shares during the quarter. Swiss National Bank’s holdings in Humana were worth $61,200,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Montag A & Associates Inc. raised its position in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC boosted its position in shares of Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana during the fourth quarter valued at approximately $27,000. Reflection Asset Management bought a new position in shares of Humana during the fourth quarter valued at approximately $29,000. Finally, Larson Financial Group LLC grew its stake in shares of Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Up 1.7%

Shares of NYSE HUM opened at $404.80 on Wednesday. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The firm has a market capitalization of $48.60 billion, a price-to-earnings ratio of 43.29, a PEG ratio of 2.17 and a beta of 0.71. The stock has a 50 day moving average price of $358.69 and a 200 day moving average price of $262.23. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period last year, the business posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts expect that Humana Inc. will post 9.46 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Needham & Company LLC began coverage on Humana in a research note on Wednesday, May 20th. They set a “buy” rating for the company. Barclays upped their price objective on Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 26th. The Goldman Sachs Group increased their target price on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. Truist Financial boosted their target price on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Finally, Piper Sandler restated a “neutral” rating and issued a $254.00 price target (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fifteen have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $327.17.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.